Le Lézard
Classified in: Health, Business
Subjects: NPT, AVO

Statement on U.S. Department of Labor filing Amicus Brief in support of Wit v. United Behavioral Health case


WASHINGTON, March 22, 2023 /PRNewswire/ -- Today, The Kennedy Forum, founded by Patrick J. Kennedy, lead author of the 2008 Mental Health Parity and Addiction Equity Act, released the statement below following the filings of amicus briefs by the U.S. Department of Labor and by 15 states and Washington, D.C. supporting a rehearing by the Ninth Circuit Court of Appeals in the Wit v. United Behavioral Health (UBH) case:

"The U.S. Department of Labor's support for a rehearing in the Wit v. United Behavioral Health (UBH) sends a powerful message that the latest Ninth Circuit panel ruling was deeply flawed and imperils the rights to millions of Americans seeking mental health and addiction treatment. When combined with the amicus brief filed by 15 states and Washington D.C. requesting a rehearing, they are a resounding statement on the need for the Ninth Circuit to rehear the Wit case en banc. We applaud the U.S. Department of Labor and the 15 states and Washington DC for working to ensure mental health and addiction services are essential, accessible, and affordable for our communities.

At The Kennedy Forum, we are working with numerous partners to ensure that mental health and addiction coverage decisions are made consistent with generally accepted standards of care, not insurers' financial self-interest. If it stands, the latest ruling will mean that more than 50,000 individuals denied mental health or addiction coverage will have no right to reprocessing of their claims, even though UBH was found to have put its self-interest ahead of plan members'. Insurers will also be given carte blanche to use any medical necessity criteria they wish to make coverage determinations, even if such criteria are inconsistent with generally accepted standards of care.

We commend the Department of Labor and the 15 states and Washington D.C. for their support for a rehearing in Wit. In the middle of our nation's mental health and addiction crisis, we cannot allow insurers to deny individuals the mental health and addiction coverage they need. We will continue to work to ensure that mental health is treated as essential health."

About The Kennedy Forum

Founded in 2013 by former Congressman Patrick J. Kennedy (D-R.I.), The Kennedy Forum leads a national dialogue on transforming the health care system by uniting mental health advocates, business leaders, and policymakers around a common set of principles, including full implementation of the Federal Parity Law. Launched in celebration of the 50th anniversary of President Kennedy's signing of the landmark Community Mental Health Act, the nonprofit aims to achieve health equity by advancing evidence-based practices, policies, and programming for the treatment of mental health and addiction. The Kennedy Forum's "Don't Deny Me" campaign educates consumers and providers about patient rights under the Federal Parity Law and connects them with essential appeals guidance and resources. To learn more about The Kennedy Forum and donate, please visit www.thekennedyforum.org.

SOURCE The Kennedy Forum


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: